InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Discover the detailed record of transactions filed by Rosa David A, Chief Executive Officer. Officer active across 2 companies, notably Biotricity INC.. Cumulatively, 8 reports have been published. Total volume traded: €126k. The latest transaction was disclosed on 3 February 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
0250,000 shares0
Common Stock
SEC:0001540354-22-000001·
0250,000 shares0
Common Stock
SEC:0001540354-22-000001:0·
027,174 shares0
Common Stock
SEC:0001493152-21-030377·
027,174 shares0
Common Stock
SEC:0001493152-21-030377:0·
€45,95217,228 shares@ €2.667372.7% of flow
Common Stock
SEC:0001493152-21-025255·
€45,95217,228 shares@ €2.66730.85% mcap36.3% of flow
Common Stock
SEC:0001493152-21-025255:0·
€17,2776,246 shares@ €2.766127.3% of flow
Common Stock
SEC:0001493152-21-024126·
€17,2776,246 shares@ €2.76610.32% mcap13.7% of flow
Common Stock
SEC:0001493152-21-024126:0·
8 of 8 declarations
About Rosa David A
David A. Rosa is a Director, CEO, and President of Biotricity Inc. and Neuroone Medical Technologies Corp. He leads the operations and strategy of both companies, focusing on innovation in the healthcare sector. Rosa plays a key role in product development and market expansion while ensuring that financial objectives are met.
